| Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160) |
|---|
| 10/05/2000 | DE10015255A1 New and known oxime derivatives used as photosensitive acid donors in chemically amplified photoresist compositions comprising a compound which is acid curable or which increases in solubility in acid |
| 10/05/2000 | CA2361016A1 Diaryl derivatives and their use as medicaments |
| 10/04/2000 | EP1041070A1 Process for preparing cyclic thioamides |
| 10/04/2000 | EP1041064A2 N-substituted alpha aminoacid amides as calcium channel modulators |
| 10/04/2000 | EP1040385A1 Thioglycerol derivatives and their use in polysulfide compositions for optical material |
| 10/04/2000 | EP1040094A1 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors |
| 10/04/2000 | EP1039902A2 Inhibitors of gap junction communication |
| 10/04/2000 | EP0848697B1 Process for the hydrogenation of imines |
| 10/04/2000 | EP0766672B1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 10/04/2000 | EP0569384B2 Fungicides |
| 10/04/2000 | CN1268937A Novel compound having effect of promoting neuron differentiation |
| 10/03/2000 | US6127568 Phenylacetic acid derivatives, preparation thereof and intermediates thereof, and compositions containing them |
| 10/03/2000 | US6127426 Antiallergic and -inflammatory agents e.g., treating psoriasis, blocked on the c-10 by a nonphenolic arylacyl or a phenylalkylidene group; lipoxygenase inhibitors; antiproliferative agents; low dosage; side effect reduction |
| 10/03/2000 | US6127394 Treatment of peroxisome proliferator-activated receptors mediated disease like cardiovascular diseases, endocrine diseases, inflammatory diseases, tumor and non-malignant proliferative diseases, neuro-psychiatric disorders |
| 10/03/2000 | US6127189 Compositions and methods for detection of an amine compound in a fingerprint |
| 10/03/2000 | US6126972 Process for the preparation of aqueous sodium methioninate solutions and use of those solutions in the production of a granulate |
| 09/30/2000 | CA2302875A1 Oxime derivatives and the use thereof as latent acids |
| 09/30/2000 | CA2302144A1 Hydroxyphenyl derivatives with hiv integrase inhibitory properties |
| 09/30/2000 | CA2267657A1 Hydroxyphenyl derivatives with hiv integrase inhibitory properties |
| 09/28/2000 | WO2000056707A1 Diaryl thioethers, compositions and uses thereof |
| 09/28/2000 | WO2000056706A1 Amino-thio-acrylonitriles as mek inhibitors |
| 09/28/2000 | WO2000056702A1 Resorcinol derivatives |
| 09/28/2000 | WO2000000483A3 Tubulin binding compounds (cobra) |
| 09/28/2000 | CA2362380A1 Amino-thio-acrylonitriles as mek inhibitors |
| 09/27/2000 | EP1038863A2 Substituted dimeric compounds, process for their preparation and pharmaceutical compositions thereof |
| 09/27/2000 | EP1037878A2 Metabotropic glutamate receptor antagonists for treating central nervous system diseases |
| 09/27/2000 | EP1037596A1 Long-acting, chemical-resistant skin emollients, moisturizers, and strengtheners |
| 09/27/2000 | EP0885188B1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors |
| 09/27/2000 | EP0848703B1 Derivatives of benzosulphonamides as inhibitors of the enzyme cyclo-oxygenase ii |
| 09/27/2000 | CN1056828C Preparation process for esters of 2,2-dimethyl-3-[(2)-1-propenyl] cyclopropane carboxylic acid and intermediates thereof |
| 09/26/2000 | US6124502 Mercaptoketones and mercaptoalcohols and a process for their preparation |
| 09/26/2000 | US6124270 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug |
| 09/26/2000 | US6124005 Fluoro-substituted alkyl ether compounds, liquid crystal compositions and liquid crystal display devices |
| 09/21/2000 | WO2000055128A1 Methods and compositions for treating leukemia |
| 09/21/2000 | WO2000055127A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3 |
| 09/21/2000 | WO2000055126A2 N-cyanomethylamides as protease inhibitors |
| 09/21/2000 | WO2000055125A2 N-cyanomethyl amides as protease inhibitors |
| 09/21/2000 | WO2000054756A2 Nitrate esters and their use for introducing neuroprotection and cognition enhancement |
| 09/21/2000 | WO2000039077A3 Thyroid receptor ligands |
| 09/21/2000 | WO2000001668A3 Naaladase inhibitors useful as pharmaceutical compounds and compositions |
| 09/21/2000 | CA2368148A1 Novel compounds and compositions as protease inhibitors |
| 09/21/2000 | CA2368122A1 Novel compounds and compositions as protease inhibitors |
| 09/21/2000 | CA2367862A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3 |
| 09/21/2000 | CA2367832A1 Methods and compositions for treating leukemia |
| 09/20/2000 | EP1036821A1 Process for the preparation of thiazine-indigo compounds and of new intermediates therefor |
| 09/20/2000 | EP1036059A1 Adamantane derivatives |
| 09/20/2000 | EP0874805B1 Phenylacetamide derivatives |
| 09/20/2000 | CN1267283A Process for preparation of 2-alkylthiobenzonitrile derivs. |
| 09/20/2000 | CN1267281A Glucagon antagonists/inverse agonists |
| 09/19/2000 | US6121496 Aromatic thioether acylation method |
| 09/19/2000 | US6121468 Process for producing amide derivatives and intermediate compounds |
| 09/19/2000 | US6121319 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 09/19/2000 | US6121316 2-cyano-3,5-dihydroxyhex-2-enecarboxamide derivatives |
| 09/19/2000 | US6121304 Pentafluorobenzenesulfonamides and analogs |
| 09/19/2000 | US6121281 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use |
| 09/19/2000 | US6120692 Use of metal dithiolene complexes in selective olefin recovery (law760) |
| 09/14/2000 | WO2000053601A1 1,2-dithiolane derivatives |
| 09/14/2000 | WO2000053583A1 Inhibitors of protein tyrosine phosphatase |
| 09/14/2000 | WO2000053577A1 Hydrazide inhibitors of hiv-1 integrase |
| 09/14/2000 | WO2000053573A1 Medicinal compositions with [2.2.1] and [3.1.1] bicycloskeleton antagonistic to both of pgd2/txa2 receptors |
| 09/14/2000 | WO2000053544A1 Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt |
| 09/14/2000 | WO2000053172A1 Ccr-3 receptor antagonists |
| 09/14/2000 | WO2000053032A1 Chelated feed additive and method of preparation |
| 09/14/2000 | WO2000003978A3 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same |
| 09/14/2000 | WO1999063999A8 H1-histamine receptor antagonists |
| 09/14/2000 | CA2366308A1 Inhibitors of protein tyrosine phosphatase |
| 09/13/2000 | EP1034163A1 New cysteine derivatives, processes for their production, and pharmaceuticals containing them |
| 09/13/2000 | EP1034154A1 A solid-phase technology for the preparation of combinatorial libraries through amide-bond anchoring |
| 09/13/2000 | EP1033910A1 Dipeptide apoptosis inhibitors and the use thereof |
| 09/13/2000 | EP0876339B1 Method for preparing mercaptocarboxylic acids from unsaturated carboxylic acids |
| 09/13/2000 | EP0871611B1 New derivatives of glycylanilides, preparation and therapeutical application |
| 09/13/2000 | EP0763017B1 N-(3-amino-2-hydroxybutyl)sulphonamide derivatives as hiv protease inhibitors |
| 09/13/2000 | CN1266430A Process for preparing optically active phenyloxirane compounds |
| 09/13/2000 | CN1056367C Process of preparing ethyl ammonia sulfate |
| 09/13/2000 | CN1056366C Method for using chicken feather to produce cystine and additive of composite amino-acid |
| 09/12/2000 | US6117987 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist like biological activity |
| 09/12/2000 | US6117870 Cyclic amide derivatives |
| 09/08/2000 | WO2000052530A1 Oxime derivatives and the use thereof as photoinitiators |
| 09/08/2000 | WO2000051975A1 Alkenyl- and alkynyl-containing metalloprotease inhibitors |
| 09/08/2000 | WO2000051972A1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy |
| 09/08/2000 | WO2000051971A1 Oxamic acids and derivatives as thyroid receptor ligands |
| 09/08/2000 | CA2365032A1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy |
| 09/08/2000 | CA2364878A1 Alkenyl- and alkynyl-containing metalloprotease inhibitors |
| 09/06/2000 | EP1032556A1 Pharmaceutically active compounds and methods of use |
| 09/06/2000 | EP0711146B1 Osmotic device having a vapor-permeable coating |
| 09/06/2000 | CN1265647A Acrylic metalloprotease inhibitor |
| 09/06/2000 | CN1265645A Urokinase inhibitors |
| 09/06/2000 | CN1265642A Aryloxyaniline derivatives |
| 09/05/2000 | US6114586 Production of stabilized and deodorized organic polysulphides |
| 09/05/2000 | US6114572 Treatment of atherosclerosis and chronic inflammatory disorders; for inhibiting cytokine-induced expression of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1, inhibiting the peroxidation of ldl lipid |
| 09/05/2000 | US6114523 Process for the recycle of a waste product of diltiazem synthesis |
| 09/05/2000 | US6114485 Thiol and sulfur-containing O-(meth)acrylate compounds and use thereof |
| 09/05/2000 | US6114372 Matrix metalloproteinase (mmp); tumor necrosis factor(tnf); compounds such as n2-((2s)-acetylmercapto)acetyl-5-phthalimidopentanoyl)-n1-((4 -methoxybenzene)sulphonyl)-n1-(phenylmethyl)hydrazine |
| 09/05/2000 | US6114364 2-((substituted)alkyl(thio, sulfonyl, or sulfoxy)methyl), 3-(carboxyl or aliphatic hydrocarbonyl)cyclopentan-1-one derivatives, except cystacyclin; use as neuron differentiation accelerator |
| 09/05/2000 | US6114163 Process for obtaining active L-α-amino carboxylic acids from corresponding racemic d, L-α-amino carboxylic acids |
| 08/31/2000 | WO2000050431A1 Platinum (ii) compounds |
| 08/31/2000 | WO2000050413A1 Novel process of preparing a benzothiazolone compound |
| 08/31/2000 | WO2000050398A2 Phenyl- and pyridinyl derivatives as neurokinin 1 antagonists |
| 08/31/2000 | WO2000050392A1 2-mercaptocarboxylic acid derivatives |
| 08/31/2000 | WO2000050391A1 Novel sulfonamide compounds and uses thereof |